Live Breaking News & Updates on Molecular Imaging

Stay updated with breaking news from Molecular imaging. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cyclopharm Limited (ASX:CYC) Insider David Heaney Acquires 10,000 Shares

Cyclopharm Limited (ASX:CYC – Get Free Report) insider David Heaney acquired 10,000 shares of the firm’s stock in a transaction dated Tuesday, October 31st. The stock was bought at an average cost of A$2.04 ($1.30) per share, for a total transaction of A$20,400.00 ($12,993.63). Cyclopharm Stock Performance The company has a current ratio of 3.90, […] ....

David Heaney , Asia Pacific , Cyclopharm Company Profile , Cyclopharm Limited , Get Free Report , Molecular Imaging , Cyclopharm Daily , Asx Cyc , Insider Trading , Nsider Trades ,

Drug Shortage of Prostate Cancer Treatment Pluvicto Resolved, FDA Finds

According to the Food and Drug Administration, the shortage of Novartis’ prostate cancer treatment Pluvicto, which began in March, has been resolved, with the manufacturer expecting a continued expansion of supply. ....

United States , New Jersey , Victor Bulto , Richard Wahl , Drug Administration , Society Of Nuclear Medicine , Nuclear Medicine , Molecular Imaging , Mallinckrodt Institute , Washington University School , Prostate Cancer ,